August 8-12, V Russian symposium “Proteins and peptides” took place in
Petrozavodsk, the general sponsor of event became the pharmaceutical
company GEROPHARM. The Russian leading scientists whose studies
dedicated to mechanism of action of peptide, methods of its receipt and
usage in pharmacology were invited to take a part in the symposium.
GEROPHARM pays great attention to research of peptide nature. Company’s
specialists regularly participate in the specialized scientific events.
The symposium in Petrozavodsk wasn’t an exception. GEROPHARM’s
scientists together with scientists of Institute of Higher Nervous
Activity and Neurophysiology of RAS, Pavlov Institute of Physiology of
RAS, Moscow State University and State Research Institute of
Pharmacology of Tomsk Scientific Center of RAMS were authors of several
reports, dedicated to creation of new peptide medicinal drugs.
The report by V. Aniol presented the results of the joint research by
group of scientists of Institute of Higher Nervous Activity and
Neurophysiology of RAS and GEROPHARM under the direction of N. Gulyaeva
has aroused a special interest. The subject of report was the study of
antiepileptic action of Cortexin. A separated stand session for young
scientists also was organized within the symposium.
Beginner researchers presented their own scientific developments of
study of the biology mechanisms of action of peptide in an organism. The
authors of the best works were regarded by GEROPHARM and charity
foundation called “Young Hippocrates” with grants to continue the
Development of peptide preparations is one of the perspective directions of the medicine development. Peptide drugs are generally recognized for their mild action and absence of contraindications as well as low dosage. Therefore GEROPHARM annually invests money in the development of innovative peptide drugs for the treatment of social significant diseases.